伽玛刀放射外科治疗三叉神经痛治疗比值的建立:生物有效剂量相较于物理剂量的关键重要性
回顾性分析1997至2010年408例三叉神经痛伽玛刀病例,采用单次4 mm等中心照射,评估物理剂量与生物有效剂量(BED)同感觉减退及无痛率的关系。物理剂量与感觉减退无显著关系,BED与感觉减退明显相关;1年及2年无痛率约90%,与BED无关。作者认为按BED处方可能更好兼顾安全与疗效。
要点
- 408例三叉神经痛患者接受单次4 mm等中心伽玛刀治疗,处方剂量75至97.9 Gy,照射时间25至135分钟。
- 物理剂量与感觉减退无显著关系,总体发生率约20%;BED与感觉减退明显相关。
- 1年及2年无痛率约90%,不随BED(1550至2600 Gy2.47)变化。
核心结论
- 结果强烈提示,处方特定BED而非物理剂量可能更好地兼顾安全性与疗效。
- 作者已制作剂量与时间到BED的换算表,以便实现等BED处方。
- 该发现可能显著改变未来的剂量规划策略,但该概念尚需在其他需要更复杂剂量规划的适应证中验证。
研究设计与样本
- 回顾性分析1997至2010年治疗的408例三叉神经痛病例,采用单次4 mm等中心,条件允许时等中心置于距三叉神经根出脑干处中位7.5 mm。
- 疗效以治疗后30天及1年、2年无痛发生率评估,并发症以感觉减退发生率评估,并分别对物理剂量与BED(采用双指数修复模型)进行评价。
主要发现
- 100%等剂量线处方剂量为75至97.9 Gy,照射时间25至135分钟。
- 物理剂量与感觉减退发生率无显著关系,总体发生率约20%。
- BED与感觉减退发生率存在明确关系,发生率从BED约1800 Gy2.47后的<5%升至约2600 Gy2.47后的42%。
- 1年及2年无痛率约90%,与BED(1550至2600 Gy2.47)无关;数据提示较低BED值时无痛状态出现更慢。
关键数值与推荐
- 处方剂量(100%等剂量线)75至97.9 Gy,照射时间25至135分钟。
- BED约1800 Gy2.47后感觉减退发生率<5%,约2600 Gy2.47后为42%。
- 1年及2年无痛率约90%,对应BED范围1550至2600 Gy2.47。
临床怎么用
- 作者认为可处方特定BED而非物理剂量,并已制作剂量与时间到BED的换算表以支持等BED处方。
- 作者指出该概念尚需在其他需要更复杂剂量规划的适应证中验证。
局限性
- 原文为回顾性分析。
- 该概念尚需在其他需要更复杂剂量规划的适应证中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: How variations of treatment time affect the safety and efficacy of Gamma Knife (GK) radiosurgery is a matter of considerable debate. With the relative simplicity of treatment planning for trigeminal neuralgia (TN), this question has been addressed in a group of these patients. Using the concept of the biologically effective dose (BED), the effect of the two key variables, dose and treatment time, were considered. METHODS: A retrospective analysis was performed of 408 TN cases treated from 1997 to 2010. Treatment involved the use of a single 4 mm isocenter. If conditions allowed, the isocenter was placed at a median distance of 7.5 mm from the emergence of the trigeminal nerve from the brain stem. The effects were assessed in terms of the incidence of the complication, hypoesthesia, and in terms of efficacy using the incidence of pain free after 30 days and 1 and 2 years. These responses were evaluated with respect to both the physical dose and the BED, the latter using a bi-exponential repair model. RESULTS: RE-evaluation showed that the prescription doses, at the 100% isodose, varied from 75 to 97.9 Gy, delivered in 25-135 minutes. The relationship between the physical dose and the incidence of hypoesthesia was not significant; the overall incidence was ∼20%. However, a clear relationship was found between the BED and the incidence of hypoesthesia, with the incidence increasing from <5% after a BED of ∼1800 Gy2.47 to 42% after ∼2600 Gy2.47. Efficacy, in terms of freedom from pain, was ∼90%, irrespective of the BED (1550-2600 Gy2.47) at 1 and 2 years. The data suggested that "pain free" status developed more slowly at lower BED values. CONCLUSIONS: These results strongly suggest that safety and efficacy might be better achieved by prescribing a specific BED instead of a physical dose. A dose and time to BED conversion table has been prepared to enable iso-BED prescriptions. This finding could dramatically change dose-planning strategies in the future. However, this concept requires validation for other indications for which more complex dose planning is required.
引用
- Tuleasca C, Paddick I, Hopewell JW, et al. Establishment of a Therapeutic Ratio for Gamma Knife Radiosurgery of Trigeminal Neuralgia: The Critical Importance of Biologically Effective Dose Versus Physical Dose. World Neurosurg. 2019. PMID: 31606504. doi:10.1016/j.wneu.2019.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。